Top Markets
#1 Akedo Akedo +113.13%
#2 TENDIES TENDIES +111.07%
#3 Threshold Network Threshold Network +50.77%
#4 Verus Coin Verus Coin +44.05%
#5 Mubarak Mubarak +27.18%
#6 Bitway Bitway +22.68%
#7 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#8 OSK OSK +16.18%
#9 MultiversX MultiversX +15.96%
#10 Cash Cat Cash Cat +15.94%
Coin of the day
Akedo Akedo
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Rankning i aktier #17592
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Aktiekurs
$8.16
Senast synkroniserad: 2025-06-26
Marknadsvärde
$234.57M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Regulus Therapeutics Inc. (RGLS)

Kategori

Healthcare
Antal utestående aktier för Regulus Therapeutics Inc. (RGLS)
Antal utestående aktier per March 2025: 66.17M
Enligt de senaste finansiella rapporterna och aktiekursen för Regulus Therapeutics Inc. är det aktuella antalet utestående aktier 66.17M. I slutet av December 2023 hade företaget 18.96M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Regulus Therapeutics Inc. (RGLS) från 2010 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 66.17M 17.44%
2024 56.35M 197.18%
2023 18.96M 24.25%
2022 15.26M 78.05%
2021 8.57M 145.03%
2020 3.50M 102.65%
2019 1.73M 97.97%
2018 871.86K 0.61%
2017 866.58K 96.90%
2016 440.11K 2.73%
2015 428.43K 16.61%
2014 367.42K 14.58%
2013 320.66K 368.55%
2012 68.44K 3,099.49%
2011 2.14K 0.00%
2010 2.14K 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 283.68%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -6.03%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 498.42%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 623.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH